港股異動 | 百濟神州(6160.HK)一度大漲20%創歷史新高 澤布替尼上市許可申請獲EMA受理
格隆匯6月26日丨百濟神州(6160.HK)今日高開高走,盤中一度大漲20%至134.4港元創歷史新高,現報126.8港元,漲13.21%,暫成交4658萬港元,最新總市值1281億港元。百濟神州今晨發公告稱,公司是一家處於商業階段的生物科技公司,專注於用於癌症治療的創新型分子靶向和腫瘤免疫藥物的開發和商業化。公司於2020年6月18日宣佈歐洲藥品管理局(EMA)已確認受理百悦澤® (澤布替尼)的上市許可申請(MAA),適用於既往接受過至少一項療法的華氏巨球蛋白血癥 (WM)患者或作為不適合化學免疫療法WM患者的一線治療方案。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.